Geoffrey S. Dow
President and CEO at 60 Degrees Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: 60 Degrees Pharmaceuticals Inc., 3 years.
60 Degrees Pharmaceuticals Inc.
Director · President and CEO
Chief executive roles
60 Degrees Pharmaceuticals Inc.
· President and CEO
Since July 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +7,350 | $1.38 | $10,143 |
| Dec 15, 2025 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +9,670 | $0.80 | $7,736 |
| Dec 11, 2025 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +3,613 | $0.92 | $3,324 |
| Dec 10, 2025 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +9,350 | $0.95 | $8,883 |
| Sep 12, 2025 | 60 Degrees Pharmaceuticals Inc. | Grant or award | +7,201 | $1.39 | $10,009 |
| Jun 9, 2025 | 60 Degrees Pharmaceuticals Inc. | Grant or award | +4,376 | $2.99 | $13,084 |
| Jan 17, 2025 | 60 Degrees Pharmaceuticals Inc. | Grant or award | +14,394 | — | — |
| Dec 9, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +35,823 | $1.27 | $45,495 |
| Dec 6, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +20,579 | $1.20 | $24,695 |
| Dec 5, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +17,549 | $1.11 | $19,479 |
| Nov 21, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +3,500 | $0.91 | $3,185 |
| Nov 20, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +1,000 | $0.92 | $920 |
| Nov 19, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +2,500 | $0.90 | $2,250 |
| May 16, 2024 | 60 Degrees Pharmaceuticals Inc. | Option exercise | +17,000 | $0.22 | $3,740 |
| Apr 12, 2024 | 60 Degrees Pharmaceuticals Inc. | Option exercise | +68,000 | $0.27 | $18,360 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.